Literature DB >> 32622746

Preoperative Pathological Grading of Hepatocellular Carcinoma Using Ultrasomics of Contrast-Enhanced Ultrasound.

Wei Wang1, Shan-Shan Wu2, Jian-Chao Zhang2, Meng-Fei Xian3, Hui Huang3, Wei Li2, Zhuo-Ming Zhou4, Chu-Qing Zhang5, Ting-Fan Wu6, Xin Li6, Ming Xu2, Xiao-Yan Xie2, Ming Kuang1, Ming-De Lu1, Hang-Tong Hu7.   

Abstract

RATIONALE AND
OBJECTIVES: To develop an ultrasomics model for preoperative pathological grading of hepatocellular carcinoma (HCC) using contrast-enhanced ultrasound (CEUS).
MATERIAL AND METHODS: A total of 235 HCCs were retrospectively enrolled, including 65 high-grade and 170 low-grade HCCs. Representative images of four-phase CEUS were selected from the baseline sonography, arterial, portal venous, and delayed phase images. Tumor ultrasomics features were automatically extracted using Ultrasomics-Platform software. Models were built via the classifier support vector machine, including an ultrasomics model using the ultrasomics features, a clinical model using the clinical factors, and a combined model using them both. Model performances were tested in the independent validation cohort considering efficiency and clinical usefulness.
RESULTS: A total of 1502 features were extracted from each image. After the reproducibility test and dimensionality reduction, 25 ultrasomics features and 3 clinical factors were selected to build the models. In the validation cohort, the combined model showed the best predictive power, with an area under the curve value of 0.785 (95% confidence interval [CI] 0.662-0.909), compared to the ultrasomics model of 0.720 (95% CI 0.576-0.864) and the clinical model of 0.665 (95% CI 0.537-0.793). Decision curve analysis suggested that the combined model was clinically useful, with a corresponding net benefit of 0.760 compared to the other two models.
CONCLUSION: We presented an ultrasomics-clinical model based on multiphase CEUS imaging and clinical factors, which showed potential value for the preoperative discrimination of HCC pathological grades.
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Hepatocellular carcinoma; Pathological grade; Ultrasomics

Year:  2020        PMID: 32622746     DOI: 10.1016/j.acra.2020.05.033

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Authors:  Xian Wang; Enock Adjei Agyekum; Yongzhen Ren; Jin Zhang; Qing Zhang; Hui Sun; Guoliang Zhang; Feiju Xu; Xiangshu Bo; Wenzhi Lv; Shudong Hu; Xiaoqin Qian
Journal:  Front Oncol       Date:  2021-03-04       Impact factor: 6.244

2.  Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study.

Authors:  Shanshan Ren; Qian Li; Shunhua Liu; Qinghua Qi; Shaobo Duan; Bing Mao; Xin Li; Yuejin Wu; Lianzhong Zhang
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

3.  The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.

Authors:  Lei Tang; Yan Zhang; Qiong Zhou; Qiaojun Hong; Zhanggui Wang
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

Review 4.  Artificial intelligence in liver ultrasound.

Authors:  Liu-Liu Cao; Mei Peng; Xiang Xie; Gong-Quan Chen; Shu-Yan Huang; Jia-Yu Wang; Fan Jiang; Xin-Wu Cui; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

5.  Machine learning prediction of prostate cancer from transrectal ultrasound video clips.

Authors:  Kai Wang; Peizhe Chen; Bojian Feng; Jing Tu; Zhengbiao Hu; Maoliang Zhang; Jie Yang; Ying Zhan; Jincao Yao; Dong Xu
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

6.  Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.

Authors:  Ruizhi Gao; Hui Qin; Peng Lin; Chenjun Ma; Chengyang Li; Rong Wen; Jing Huang; Da Wan; Dongyue Wen; Yiqiong Liang; Jiang Huang; Xin Li; Xinrong Wang; Gang Chen; Yun He; Hong Yang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.